» Articles » PMID: 21528082

Gastric Cancer Cells Induce Human CD4+Foxp3+ Regulatory T Cells Through the Production of TGF-β1

Overview
Specialty Gastroenterology
Date 2011 Apr 30
PMID 21528082
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To elucidate the molecular and cellular features responsible for the increase of regulatory T cells (Tregs) in gastric cancer.

Methods: The frequencies of CD4(+)Foxp3(+) Tregs and the level of transforming growth factor-β1 (TGF-β1) were analyzed from 56 patients with gastric cancer by flow cytometry and enzyme-linked immunosorbent assay respectively. Foxp3 gene expression was analyzed by real-time polymerase chain reaction. The gastric cancer microenvironment was modeled by establishing the co-culture of gastric cancer cell line, MGC-803, with sorting CD4(+) T cells. The normal gastric mucosa cell line, GES-1, was used as the control. The production of TGF-β1 was detected in supernatant of MGC and GES-1. The carboxyfluorescein diacetatesuccinimidyl ester (CFSE) dilution assay was performed to evaluate the proliferation characteristics of induced Tregs. Neutralizing anti-TGF-β1 antibody was added to the co-culture system for neutralization experiments.

Results: The level of serum TGF-β1 in gastric cancer patients (15.1 ± 5.5 ng/mL) was significantly higher than that of the gender- and age-matched healthy controls (10.3 ± 3.4 ng/mL) (P < 0.05). Furthermore, the higher TGF-β1 level correlated with the increased population of CD4(+)Foxp3(+) Tregs in advanced gastric cancer (r = 0.576, P < 0.05). A significant higher frequency of CD4(+)Foxp3(+) Tregs was observed in PBMCs cultured with the supernatant of MGC than GES-1 (10.6% ± 0.6% vs 8.7% ± 0.7%, P < 0.05). Moreover, using the purified CD4(+)CD25(-) T cells, we confirmed that the increased Tregs were mainly induced from the conversation of CD4(+)CD25(-) naive T cells, and induced Tregs were functional and able to suppress the proliferation of effector T cells. Finally, we demonstrated that gastric cancer cells induced the increased CD4(+)Foxp3(+) Tregs via producing TGF-β1. Gastric cancer cells upregulated the production of TGF-β1 and blockade of TGF-β1 partly abrogated Tregs phenotype.

Conclusion: Gastric cancer cell can induce Tregs development via producing TGF-β1, by which the existence of cross-talk between the tumor and immune cells might regulate anti-tumor immune responses.

Citing Articles

Molecular Mechanism for Malignant Progression of Gastric Cancer Within the Tumor Microenvironment.

Matsuoka T, Yashiro M Int J Mol Sci. 2024; 25(21).

PMID: 39519285 PMC: 11546171. DOI: 10.3390/ijms252111735.


T lymphocyte‑related immune response and immunotherapy in gastric cancer (Review).

Zhang Z, Zhang W, Liu X, Yan Y, Fu W Oncol Lett. 2024; 28(5):537.

PMID: 39319215 PMC: 11421013. DOI: 10.3892/ol.2024.14670.


Investigation of risk factors for metachronous recurrence in patients with early gastric adenocarcinoma by miRNA-mRNA integral profiling.

Nagashima A, Okimoto K, Nakagawa R, Akizue N, Matsumura T, Oura H Sci Rep. 2023; 13(1):19661.

PMID: 37952025 PMC: 10640628. DOI: 10.1038/s41598-023-47000-3.


Pyrolyzed deketene curcumin controls regulatory T cell generation and gastric cancer metabolism cooperate with 2-deoxy-d-glucose.

Maruyama T, Miyazaki H, Lim Y, Gu J, Ishikawa M, Yoshida T Front Immunol. 2023; 14:1049713.

PMID: 36814928 PMC: 9939626. DOI: 10.3389/fimmu.2023.1049713.


In Vitro Evidence of Differential Immunoregulatory Response between MDA-MB-231 and BT-474 Breast Cancer Cells Induced by Bone Marrow-Derived Mesenchymal Stromal Cells Conditioned Medium.

Arenas-Luna V, Montesinos J, Cortes-Morales V, Navarro-Betancourt J, Peralta-Ildefonso J, Cisneros B Curr Issues Mol Biol. 2023; 45(1):268-285.

PMID: 36661506 PMC: 9857683. DOI: 10.3390/cimb45010020.


References
1.
Teicher B . Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Rev. 2002; 20(1-2):133-43. DOI: 10.1023/a:1013177011767. View

2.
Flavell R, Sanjabi S, Wrzesinski S, Licona-Limon P . The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol. 2010; 10(8):554-67. PMC: 3885992. DOI: 10.1038/nri2808. View

3.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View

4.
Wrzesinski S, Wan Y, Flavell R . Transforming growth factor-beta and the immune response: implications for anticancer therapy. Clin Cancer Res. 2007; 13(18 Pt 1):5262-70. DOI: 10.1158/1078-0432.CCR-07-1157. View

5.
Beyer M, Schultze J . Regulatory T cells in cancer. Blood. 2006; 108(3):804-11. DOI: 10.1182/blood-2006-02-002774. View